Literature DB >> 1607224

Vascular changes and their mechanisms in the feline model of retinopathy of prematurity.

T Chan-Ling1, S Tout, H Holländer, J Stone.   

Abstract

This study documents changes to retinal vasculature during the feline form of retinopathy of prematurity (ROP). The authors describe the closure and obliteration of retinal vessels during exposure to high oxygen, the pattern and tempo of growth of proliferative vasculature, which, after the return of the animal to room air, extends from the optic disc in a spectacular "rosette" pattern, the formation of preretinal vascular growths, and an initial lack of barrier properties in the new vessels. Finally, the response of the vasculature to the relief of hypoxia is reported, including the gradual establishment of barrier properties in the intraretinal vessels, the partial normalization of the proliferative vessels, and the abnormalities that persist. It is suggested that the vascular changes occur in successive stages: closure and obliteration during hyperoxia, vasoproliferation induced by hypoxia, and normalization after the relief of hypoxia with distinct cellular mechanisms and stimuli. It is argued that the same stages can be seen in the human form of ROP; two possible stimuli for the fibroplasia that damages the retina in human ROP are discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1607224

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  22 in total

1.  Breakdown of the blood-retinal barrier induced by activated T cells of nonneural specificity.

Authors:  P Hu; J D Pollard; T Chan-Ling
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

Review 2.  Retinopathy of prematurity: recent advances in our understanding.

Authors:  C M Wheatley; J L Dickinson; D A Mackey; J E Craig; M M Sale
Journal:  Br J Ophthalmol       Date:  2002-06       Impact factor: 4.638

Review 3.  Retinopathy of prematurity: recent advances in our understanding.

Authors:  C M Wheatley; J L Dickinson; D A Mackey; J E Craig; M M Sale
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-09       Impact factor: 5.747

Review 4.  The mouse retina as an angiogenesis model.

Authors:  Andreas Stahl; Kip M Connor; Przemyslaw Sapieha; Jing Chen; Roberta J Dennison; Nathan M Krah; Molly R Seaward; Keirnan L Willett; Christopher M Aderman; Karen I Guerin; Jing Hua; Chatarina Löfqvist; Ann Hellström; Lois E H Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06       Impact factor: 4.799

Review 5.  Retinopathy of prematurity.

Authors:  Deepak Chawla; Ramesh Agarwal; Ashok Deorari; Vinod K Paul; Parijat Chandra; Rajvardhan V Azad
Journal:  Indian J Pediatr       Date:  2010-10-27       Impact factor: 1.967

Review 6.  Adenosine receptors and caffeine in retinopathy of prematurity.

Authors:  Jiang-Fan Chen; Shuya Zhang; Rong Zhou; Zhenlang Lin; Xiaohong Cai; Jing Lin; Yuqing Huo; Xiaoling Liu
Journal:  Mol Aspects Med       Date:  2017-01-11

7.  Scanning electron microscopy of cochlea in new-born rats exposed to hyperbaric oxygen: preliminary report.

Authors:  P M Picciotti; S E Agostino; W Di Nardo; E Scarano
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-10       Impact factor: 2.124

8.  Correlation between enhanced vascular permeability, up-regulation of cellular adhesion molecules and monocyte adhesion to the endothelium in the retina during the development of fatal murine cerebral malaria.

Authors:  N Ma; N H Hunt; M C Madigan; T Chan-Ling
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

Review 9.  Animal models of choroidal and retinal neovascularization.

Authors:  Hans E Grossniklaus; Shin J Kang; Lennart Berglin
Journal:  Prog Retin Eye Res       Date:  2010-05-19       Impact factor: 21.198

Review 10.  Understanding ischemic retinopathies: emerging concepts from oxygen-induced retinopathy.

Authors:  Elsa Kermorvant-Duchemin; Przemyslaw Sapieha; Mirna Sirinyan; Martin Beauchamp; Daniella Checchin; Pierre Hardy; Florian Sennlaub; Pierre Lachapelle; Sylvain Chemtob
Journal:  Doc Ophthalmol       Date:  2009-10-31       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.